首页> 外文期刊>Veterinary Research Communications >Investigation of serum concentrations and immunohistochemical localization of α1-acid glycoprotein in tumor dogs
【24h】

Investigation of serum concentrations and immunohistochemical localization of α1-acid glycoprotein in tumor dogs

机译:肿瘤犬血清α1-酸性糖蛋白浓度及免疫组化定位的研究

获取原文
获取原文并翻译 | 示例
       

摘要

The purpose of this study was to measure the dynamics of serum α1-acid glycoprotein (AGP) concentration in dogs with various tumors, and to investigate the localization of AGP in some tissues using immunohistochemical staining. Sera were obtained from 171 dogs bearing tumors of various types. Serum AGP concentration was measured by single radial immunodiffusion. Tumors occurring in the liver and spleen were also investigated immunohistochemically using anti-canine AGP antibody. Mean serum AGP levels were 749 ± 602 mg/L in dogs with carcinoma (n = 39), 1,014 ± 971 mg/L with sarcoma (n = 18), and 887 ± 935 mg/L with round cell tumors (n = 46), all significantly higher than serum AGP level in healthy dogs (n = 137, 364 ± 106 mg/L). Mean serum AGP levels were significantly higher than in healthy dogs in complex mammary gland carcinoma (n = 5, 876 ± 721 mg/L), malignant melanoma (n = 7, 1,010 ± 821 mg/L), and hepatocellular carcinoma (n = 5, 936 ± 741 mg/L) among carcinomas, hemangiosarcoma (n = 5, 1,740 ± 1,323 mg/L) among sarcomas, and lymphoma (n = 19, 1,072 ± 965 mg/L) and histiocytic tumor (n = 6, 1,800 ± 1,387 mg/L) among round cell tumors. In an immunohistochemical investigation of AGP localization, both weak and strong staining for anti-AGP antibody were seen in hepatic tissue in dogs with primary non-tumorous lesions originating in the spleen (hematoma) and elevated serum AGP, but all tumor tissue in the spleen was negative. Among dogs with primary tumor lesions of the spleen (hemangiosarcoma) and elevated serum AGP levels, both weak, moderate and strong staining for anti-AGP antibody were seen in hepatic tissue, while strong positive staining was apparent in all tumorous tissue from the spleen. In primary tumor lesions in the liver (hepatocellular carcinoma), both moderate and strong staining for anti-AGP antibody were seen in normal hepatic tissue, and both weak, moderate and strong staining were seen in tumor tissues of the liver. AGP levels thus appear to be elevated in dogs with carcinomas, sarcomas, and round cell tumors. With some of these malignant tumors, localization of AGP in tumor tissue was seen.
机译:这项研究的目的是测量各种肿瘤犬的血清α1-酸性糖蛋白(AGP)浓度的动态,并使用免疫组织化学染色研究AGP在某些组织中的定位。从171例携带各种类型肿瘤的狗中获得血清。血清AGP浓度通过单次放射免疫扩散法测定。还使用抗犬AGP抗体免疫组织化学研究了肝脏和脾脏中发生的肿瘤。患有癌的狗(n = 39)的平均血清AGP水平为749±602 mg / L,患有肉瘤的狗(n = 18)为1,014±971 mg / L,患有圆形细胞肿瘤的狗(n = 46)为887±935 mg / L ),均显着高于健康犬的血清AGP水平(n = 137,364±106 mg / L)。在复杂的乳腺癌(n = 5,876±721 mg / L),恶性黑色素瘤(n = 7,1,010±821 mg / L)和肝细胞癌(n = 5,平均血清AGP水平显着高于健康犬。在癌症中为5,936±741 mg / L),在肉瘤中为血管肉瘤(n = 5,1,740±1,323 mg / L),淋巴瘤(n = 19,1,072±965 mg / L)和组织细胞性肿瘤(n = 6, 1,800±1,387 mg / L)。在AGP定位的免疫组织化学研究中,在患有原发性非肿瘤性病变(血肿),血清AGP升高但脾脏中所有肿瘤组织的犬的肝组织中,抗AGP抗体的染色均呈弱和强染色是负面的。在患有原发性脾脏肿瘤(血管肉瘤)和血清AGP水平升高的犬中,肝组织中均见到抗AGP抗体的弱,中和强染色,而在脾的所有肿瘤组织中均可见强阳性染色。在肝脏的原发性肿瘤病变(肝细胞癌)中,正常肝组织中抗AGP抗体均出现中度和强度染色,而肝脏肿瘤组织中均出现了弱,中度和强度染色。因此,患有癌症,肉瘤和圆形细胞瘤的狗的AGP水平似乎升高。对于其中一些恶性肿瘤,可以看到AGP在肿瘤组织中的定位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号